Skip to the page
pepts.wiki

We are not doctors and nothing here is medical advice. Always consult a medical professional first. Why we say this

Studied in peopleStub

Kisspeptin-10

Kisspeptin fragment

The shortest active form of kisspeptin, the hormone that switches on the reproductive axis, studied in people for its effect on LH release.

Reconstitution calculator

At a glance

Studied in people

There are published studies in people. It is not a licensed medicine in the United States or the European Union.

This page is a stub

The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.

How strong is the evidence

How far it has climbed

Every medicine climbs the same ladder. Most compounds never reach the top, and where one stands says how much its claims can carry.

  1. Licensed medicine

    A regulator has reviewed the trials and licensed it for a named use.

  2. Phase 3

    Large randomized trials, often thousands of people, against placebo or a standard treatment.

  3. Phase 2

    Mid-sized trials that measure dose against effect in people with the condition.

  4. Phase 1 and early human studies: Kisspeptin-10

    First studies in people: safety, and how the body handles it.

  5. Cells and animals

    Laboratory and animal work. An animal result is not a result in people.

319
papers on PubMed
111
of them in people
5
randomized trials
13
reviews

A count says how much has been published, not what it found. Counted on PubMed: 2026-11-16

Handling and reconstitution

From powder to a measured sample

The same four steps for any lyophilized vial. Laboratory handling, not use in a person.

  1. 1. Read the vial

    The label gives the mass of peptide in the vial, in milligrams. That number is the start of every calculation.

  2. 2. Add the diluent

    A measured volume of diluent goes in slowly, down the glass. Swirl gently; shaking can damage a peptide.

  3. 3. Work out the strength

    Concentration is mass divided by volume: 10 mg in 2 mL is 5 mg per mL.

  4. 4. Measure the sample

    Volume is the mass wanted divided by the concentration. On a U-100 syringe, 1 mL is 100 units.

The calculator below does the arithmetic and shows its working.

As powder

General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.

In solution

Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.

This is general practice for lyophilized peptides, not data on Kisspeptin-10 itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage

Reconstitution calculator

Opens on vial sizes common for research peptides. Change any number. How the arithmetic works

Draw to

10 units

0.1 mL on a U-100 syringe

Concentration
2.5 mg/mL
Each unit holds
25 mcg
Samples in the vial
20
Sample
250 mcg

5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of Kisspeptin-10; no amount here is a recommendation.

Kisspeptin-10: on PubMed

What PubMed held for Kisspeptin-10 on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.

319
papers
111
in humans
9
clinical trials
5
randomized trials
2012: 14 papers122013: 15 papers2014: 19 papers142015: 14 papers2016: 15 papers162017: 26 papers2018: 22 papers182019: 16 papers2020: 19 papers202021: 13 papers2022: 20 papers222023: 11 papers2024: 10 papers242025: 21 papers2026: 24 papers so far26
Papers per year, 2012 to 2026. The most in one year: 26.

Most relevant on PubMed

Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.

  1. Age-dependent changes in the reproductive axis responsiveness to kisspeptin-10 administration in healthy men

    TrialUllah H, Nabi G, Zubair H, et al. Andrologia, 2019. PMID 30590872

  2. An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo

    Randomized trialKeen KL, Wegner FH, Bloom SR, et al. Endocrinology, 2008. PMID 18450954

  3. Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men

    Randomized trialYeung AC, Phylactou M, Koysombat K, et al. European journal of endocrinology, 2026. PMID 42549827

  4. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males

    Randomized trialDhillo WS, Chaudhri OB, Patterson M, et al. The Journal of clinical endocrinology and metabolism, 2005. PMID 16174713

  5. Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men

    TrialGeorge JT, Veldhuis JD, Roseweir AK, et al. The Journal of clinical endocrinology and metabolism, 2011. PMID 21632807

  6. Characteristics of stimulation of gonadotropin secretion by kisspeptin-10 in female goats

    StudyHashizume T, Saito H, Sawada T, et al. Animal reproduction science, 2010. PMID 19574004

  7. Investigating the detection of the novel doping‐relevant peptide kisspeptin‐10 in urine using liquid chromatography high‐resolution mass spectrometry

    StudyColpaert T, Risseeuw M, Deventer K, et al. Biomedical chromatography : BMC, 2024. PMID 38978171

  8. Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of Src

    StudyLi Z, Yang X, Fu R, et al. Nature communications, 2024. PMID 38346942

Search used: ("kisspeptin-10"[tiab]). Run it on PubMed

Research links

Also in Hormonal